摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cyclooctyl carboxaldehyde dimethyl acetal | 62034-88-2

中文名称
——
中文别名
——
英文名称
cyclooctyl carboxaldehyde dimethyl acetal
英文别名
Dimethoxymethylcyclooctane
cyclooctyl carboxaldehyde dimethyl acetal化学式
CAS
62034-88-2
化学式
C11H22O2
mdl
——
分子量
186.294
InChiKey
INLVFESKERWLQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    213.6±8.0 °C(Predicted)
  • 密度:
    0.900±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:4d81d45971e9eb1768b9f1e456f8d738
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of J-113397, the first potent and selective ORL1 antagonist
    摘要:
    The first potent and selective small molecule ORL1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-1-3-dihydro-2H-benzimidazol-2-one (J- 113397)was synthesized. J-113397 is the only available potent and selective ORL1 antagonist, which is a very useful pharmacological tool for elucidating the physiological roles of the nociceptin-ORL1 system. J-113397 was synthesized from ethyl 4-oxo-3-piperidinecarboxylate and a coupling reaction of 2-fluorobenzene with 4-amino-ethoxycarbonylpiperidine is a key step. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(00)01064-4
  • 作为产物:
    参考文献:
    名称:
    Acetal derivatives of cyclooctyl carboxaldehydes
    摘要:
    环辛基羰基和其缩醛衍生物可用作芳香组合物,可以单独使用或与其他化合物混合使用。
    公开号:
    US03985769A1
点击查看最新优质反应信息

文献信息

  • Phosphonium-based aminophosphines as bifunctional ligands for sequential catalysis of one-pot hydroformylation–acetalization of olefins
    作者:Peng Wang、Huan Liu、Yong-Qi Li、Xiao-Li Zhao、Yong Lu、Ye Liu
    DOI:10.1039/c5cy01827g
    日期:——
    involved bifunctional moieties of the phosphine fragment and Lewis acidic phosphonium were linked together by stable chemical bonds and bridged by one N-atom. The molecular structure of the L2-ligated Rh-complex (Rh-L2) indicated that such bifunctionalities were well retained without incompatibility problems. Investigations on co-catalysis over L1–L3 showed that L3 exhibited the best sequential catalysis
    制备并充分表征了一系列基于离子phospho的氨基膦L1 - L3,其中每个膦片段的双功能部分和路易斯酸性phospho通过稳定的化学键连接在一起,并通过一个N原子桥接。与L 2连接的Rh-络合物(Rh-L 2)的分子结构表明,这样的双官能团被很好地保留而没有不相容性问题。在L1 - L3上进行共催化的研究表明,L3在加氢甲酰化和乙缩醛化方面均表现出最佳的顺序催化。L3中的膦片段与Rh配合物一起负责加氢甲酰化反应,而as则充当路易斯酸催化剂,负责乙缩醛化反应。该L3 -Rh(ACAC)(CO)2系统也显示出良好的通用大范围在不同的醇的烯烃的加氢甲酰化,缩醛化。
  • Phosphine-ligated Ir(III)-complex as a bi-functional catalyst for one-pot tandem hydroformylation-acetalization
    作者:Huan Liu、Lei Liu、Wen-Di Guo、Yong Lu、Xiao-Li Zhao、Ye Liu
    DOI:10.1016/j.jcat.2019.04.004
    日期:2019.5
    IrIII-Lewis acid for tandem hydroformylation-acetalization of olefins. The best result was obtained over L5-based IrCl3⋅3H2O catalytic system which corresponded to 97% conversion of 1-hexene along with 92% selectivity to the target acetals free of any additive. The crystal structure of the novel IrIII-complex of IrIII-L4 indicated that the electron-deficient nature of the involved phosphine warranted Ir-center
    的的IrCl络合3 ⋅3H 2 O,其缺电子膦(L1 - L6)分别得到具有过渡金属络合物(Ir中的双重功能的双功能催化剂III -P)和Ir III -Lewis酸为串联加氢甲酰化-烯烃的缩醛化。得到最好的结果超过L5系的IrCl 3 ⋅3H 2 ö催化其对应于1-己烯的转化率为97%与92%的选择性,以缩醛释放任何添加剂的目标沿着系统。新颖的铱的晶体结构III -配合物的铱III -L4指出所涉及的膦的电子缺陷性质保证了其在+3价态的Ir中心没有还原,这也用作随后醛的乙缩醛化的路易斯酸催化剂。此外,作为离子膦,L6系的IrCl 3 ⋅3H 2 ö固定在[BMIM] PF的RTIL系统6可以再循环用于6次没有明显的活性损失或金属浸出。
  • US3985769A
    申请人:——
    公开号:US3985769A
    公开(公告)日:1976-10-12
  • Synthesis of J-113397, the first potent and selective ORL1 antagonist
    作者:Hiroshi Kawamoto、Hiroshi Nakashima、Tetsuya Kato、Sachie Arai、Kenji Kamata、Yoshikazu Iwasawa
    DOI:10.1016/s0040-4020(00)01064-4
    日期:2001.2
    The first potent and selective small molecule ORL1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-1-3-dihydro-2H-benzimidazol-2-one (J- 113397)was synthesized. J-113397 is the only available potent and selective ORL1 antagonist, which is a very useful pharmacological tool for elucidating the physiological roles of the nociceptin-ORL1 system. J-113397 was synthesized from ethyl 4-oxo-3-piperidinecarboxylate and a coupling reaction of 2-fluorobenzene with 4-amino-ethoxycarbonylpiperidine is a key step. (C) 2001 Elsevier Science Ltd. All rights reserved.
  • Acetal derivatives of cyclooctyl carboxaldehydes
    申请人:Universal Oil Products Company
    公开号:US03985769A1
    公开(公告)日:1976-10-12
    Cyclooctyl carboxaldehydes and acetal derivatives thereof may be utilized as fragrant compositions, either alone or in admixture with other compounds.
    环辛基羰基和其缩醛衍生物可用作芳香组合物,可以单独使用或与其他化合物混合使用。
查看更多